Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 10:49 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 75 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Wound, Non-Healed Clear all

Conditions: Venous Leg Ulcer, Venous Ulcer, Venous Stasis Ulcer, Venous Stasis, Wound Heal, Wound, Venous Insufficiency of Leg, Non-healing Wound
Interventions: TR987 0.1% gel + Standard of Care, Standard of care; Drug · Other
Lead sponsor: TR Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 4
States / cities: Jacksonville, Florida • Clinton Twp, Michigan • Lake Success, New York + 1 more

Conditions: Venous Leg Ulcers
Interventions: Aurix; Device
Lead sponsor: Nuo Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 640 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 23
States / cities: Arcadia, California • Montebello, California • Visalia, California + 16 more

Conditions: Diabetic Foot Ulcers, Venous Stasis Ulcer, Pressure Ulcer, Chronic Non Healing Wound, Surgical Wound Dehiscence
Interventions: Cellular and tissue based products; Biological
Lead sponsor: U.S. Wound Registry; Other
Eligibility: Not listed
Enrollment: 50,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 1
States / cities: The Woodlands, Texas

Conditions: Pressure Ulcer
Interventions: AutoloGel; Device
Lead sponsor: Cytomedix; Industry
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Pascagaula, Mississippi

Conditions: Diabetic Foot Ulcer
Interventions: Vaporous Hyperoxia Therapy; Device
Lead sponsor: Vaporox; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 3
States / cities: Castle Rock, Colorado • Denver, Colorado

Conditions: Diabetic Foot Ulcer, Surgical Wound
Interventions: Natrox® Oxygen Wound Therapy; Device
Lead sponsor: Inotec AMD Limited; Industry
Eligibility: 18 Years and older
Enrollment: 145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 19
States / cities: Los Angeles, California • Miami, Florida • Miami Lakes, Florida + 15 more

Conditions: Diabetic Foot Ulcer
Interventions: OptiPulse™, Standard of Care offloading device; Device
Lead sponsor: Compedica Inc; Industry
Eligibility: 18 Years and older
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 18
States / cities: Phoenix, Arizona • Los Angeles, California • Vista, California + 12 more

Conditions: Critical Limb Ischemia
Interventions: Oxygenesys(TM) Dissolved Oxygen Dressing; Device
Lead sponsor: Halyard Health; Industry
Eligibility: 21 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Diabetic Foot Ulcers
Interventions: AutoloGel; Device
Lead sponsor: Cytomedix; Industry
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Arcadia, California • Cumming, Georgia

Conditions: Non-healing Wound
Interventions: CeFAZolin Injectable Solution; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Venous Leg Ulcer
Interventions: AutoloGel; Device
Lead sponsor: Cytomedix; Industry
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Arcadia, California • Cumming, Georgia

Conditions: Non-healing Wound, Diabetic Foot Ulcer
Interventions: AC5® Advanced Wound System, Fibracol Plus Collagen Dressing; Device
Lead sponsor: Arch Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Greenville, North Carolina • Circleville, Ohio

Conditions: Wounds and Injuries, Burns, Mohs Surgery, Diabetic Foot Ulcer Mixed, Venous Leg Ulcer, Non-healing Wound, Trauma Injury, Injury and Wounds, Degloving Injuries, Pressure Ulcers, Bedsores, Decubitus Ulcer
Interventions: Various types of wound care treatments; Combination Product
Lead sponsor: Siddhey LLC; Industry
Eligibility: 18 Years and older
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 12
States / cities: Scottsdale, Arizona • Tempe, Arizona • Tucson, Arizona + 8 more

Conditions: Non-healing Wound
Interventions: Platelet Rich Plasma; Other
Lead sponsor: St Elizabeth Healthcare; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Edgewood, Kentucky

Conditions: Diabetes, Diabetic Foot Ulcer, Non-healing Wound
Interventions: ExpressGraft-C9T1 Skin Tissue; Biological
Lead sponsor: Stratatech, a Mallinckrodt Company; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Foot Ulcer Chronic, Skin Ulcer Venous Stasis Chronic, Pressure Ulcer
Interventions: Platelet Rich Plasma, Standard of Care; Procedure
Lead sponsor: ACR Biologics, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Pressure Ulcer
Interventions: Aurix; Device
Lead sponsor: Nuo Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 22
States / cities: Arcadia, California • Montebello, California • Visalia, California + 16 more

Conditions: Venous Leg Ulcer, Chronic Non-Healing Cutaneous Wounds, VLU
Interventions: LUT017 gel; Drug
Lead sponsor: Antoni Ribas; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Non-healing Wound, Non-Healing Ulcer of Skin
Interventions: Omeza Products Used in Combination; Combination Product
Lead sponsor: Omeza, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Santa Fe, New Mexico

Conditions: Diabetic Foot Ulcers
Interventions: Aurix; Device
Lead sponsor: Nuo Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 760 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 20
States / cities: Arcadia, California • Montebello, California • Visalia, California + 14 more

Conditions: Diabetic Foot Ulcer
Interventions: BR-AC, Standard Care; Other
Lead sponsor: BioStem Technologies; Industry
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 11
States / cities: San Francisco, California • Sylmar, California • Torrance, California + 8 more

Conditions: Diabetic Foot Ulcer
Interventions: Dual-layer perinatal tissue allograft, Three-layer fenestrated perinatal tissue allograft, Standard of care; Other
Lead sponsor: Samaritan Biologics; Industry
Eligibility: 18 Years and older
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Monroe, North Carolina

Conditions: Diabetic Foot, Diabetic Foot Ulcer, Foot Ulcer, Chronic Foot Ulcer
Interventions: Symphony™ plus Off-loading, Wound Dressing comprising of calcium alginate Fibracol; Device
Lead sponsor: Aroa Biosurgery Limited; Industry
Eligibility: 18 Years and older
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 11
States / cities: Los Angeles, California • San Francisco, California • Miami, Florida + 7 more

Conditions: Pyoderma Gangrenosum
Interventions: Bimekizumab; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Portland, Oregon

Search by objective public record fields.

Tissue Repair Gel in Venous Leg Ulcers in AU/US

Effectiveness of Aurix Therapy in Venous Leg Ulcers

Cellular and Tissue Based Therapy Registry

AutoloGel Therapy to Usual and Customary Care in Pressure Ulcers

Effectiveness of Vaporous Hyperoxia Therapy (VHT) in the Treatment of Chronic Diabetic Foot Ulcers

The Effect of Natrox® Oxygen Wound Therapy on the Healing Rate of Chronic Diabetic Foot Ulcers

A Clinical Investigation Evaluating Wound Closure With OptiPulse™ Versus SOC in the Treatment of Non-Healing DFU's

Dissolved Oxygen Dressing to Improve Chronic Wound Healing After Revascularization for Critical Limb Ischemia

Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers

Antibiotic Tumescent For Chronic Wounds

A Cohort Trial Comparing AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers

Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers

Clinical Registry Collecting Real World Evidence on Wound Care Treatments

Kerecis Fish Skin Grafts With and Without Platelet Rich Plasma (PRP)

ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers

Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Non-Healing Wounds

Effectiveness of Aurix Therapy in Pressure Ulcers

LUT017 Gel for Venous Leg Ulcers and Chronic Non-Healing Skin Wounds in Adults

Omeza Combination Therapy for the Management and Treatment of Chronic Cutaneous Wounds/Ulcers of Multiple Etiologies

Effectiveness of Aurix Therapy in Diabetic Foot Ulcers

A Prospective Trial of Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AC

Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.

Clinical Study Evaluating Symphony™ Versus Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers

Efficacy of Bimekizumab in Adults With Pyoderma Gangrenosum